Vivos Therapeutics, Inc. (NASDAQ:VVOS) Might Not Be As Mispriced As It Looks After Plunging 45%
Unfortunately for some shareholders, the Vivos Therapeutics, Inc. (NASDAQ:VVOS) share price has dived 45% in the last thirty days, prolonging recent pain. The recent drop completes a disastrous twe
Vivos Therapeutics Sees Increased Adoption of Oral Medical Devices From Medicare Reimbursement Approval | NASDAQ:VVOS
Vivos Therapeutics Receives Approval for Medicare Reimbursement for Flagship Oral Medical Devices
What's Going On With Vivos Therapeutics Stock?
Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million shares of common stock by selling shareholders.The D
Medicare to Reimburse for Vivos CARE Sleep Apnea Devices
Market-Moving News for April 9th
LASE: 167% | Laser Photonics shares are trading higher after the company announced it secured an order for its LaserTower COMPACT marking and engraving system from L3Harris Technologies.ACRV: 87% | Ac
Express News | Vivos Therapeutics Shares Are Trading Lower. The Company Announced an Offer to Sell up to 1.7 Million Shares of Common Stock by the Selling Stockholder
Express News | Vivos Therapeutics Inc: Offer For Sale Of Up To 1.7M Shares Of Common Stock, By The Selling Stockholder
Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary
Express News | Vivos Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 17/522,740 Titled "Vibrational Oral Appliance With Mandibular Advancements (To Provide Relief From Sleep Disordered Breathing, Sleep Apnea And/Or Snoring)"
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript
Precision Biosciences, Mesoblast, Pulse Biosciences Among Healthcare Movers
Top Premarket Decliners
Fractyl Health (GUTS) shares fell 19% Monday premarket after the company reported a wider Q4 net loss. CalciMedica (CALC) shares dropped 18% following a muted session. Vivos Therapeutics (VVOS) shares
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersGalera Therapeutics (NASDAQ:GRTX) shares moved upwards by 62.8% to $0.23 during Monday's pre-market session. The market value of their outstanding shares is at $12.3 million. As per the news, t
Vivos Therapeutics Highlights Path to Cash Flow Positivity After FDA Clearance | NASDAQ:VVOS
Vivos Therapeutics Full Year 2023 Earnings: Misses Expectations
12 Health Care Stocks Moving In Friday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday's after-market session. The market value of their outstanding shares is at $37.1 million. Sunshine Biopharma (NASDAQ:SB
Earnings Call Summary | Vivos Therapeutics(VVOS.US) Q4 2023 Earnings Conference
The following is a summary of the Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript:Financial Performance:Vivos reported a Q4 2023 total revenue of $3.2 million, down from $4 million in
Vivos Therapeutics Shares Fall After Wider-Than-Expected 4Q Loss
By Mary de Wet Vivos Therapeutics shares slid late Thursday after the medical device company reported wider-than-expected loss in the fourth quarter. The stock was recently down 16% at $4.06, erasin
Express News | Vivos Therapeutics Q4 2023 GAAP EPS $(3.05) Misses $(1.91) Estimate, Sales $3.248M Miss $3.406M Estimate
No Data